The Kuwait National Primary Immunodeficiency Registry 2004-2018

Waleed Al-Herz 1 2, Mona Al-Ahmad 3 4, Ahmad Al-Khabaz 5, Ahmed Husain 6, Ali Sadek 7, Yasmeen Othman 4

Affiliations

24 July 2019

-

doi: 10.3389/fimmu.2019.01754

Abstract

Objective: To present the report from the Kuwait National Primary Immunodeficiency Registry between 2004 and 2018. 

Methods: The patients were followed prospectively between January 2004 and December 2018 and their collected data included sociodemographic, diagnosis, clinical presentation, laboratory tests, and treatment. 

Results: A total of 314 PID patients (165 males and 149 females) were registered during the study period. Most of the patients (n = 287, 91.4%) were Kuwaiti nationals and the prevalence among Kuwaitis was 20.27/100,000 with a cumulative incidence of 24.96/100,000 Kuwaitis. The distribution of the patients according to PID categories was as follow: immunodeficiencies affecting cellular and humoral immunity, 100 patients (31.8%); combined immunodeficiencies with associated syndromic features, 68 patients (21.7%); predominantly antibody deficiencies, 56 patients (17.8%); diseases of immune dysregulation, 47 patients (15%); congenital defects of phagocyte number or function, 20 patients (6.4%); autoinflammatory disorders, 1 patient (0.3%); and complement deficiencies, 22 patients (7%). The mean age of the patients at onset of symptoms was 26 months while the mean age at diagnosis was 53 months and the mean delay in diagnosis was 27 months. Most of the patients (n = 272, 86%) had onset of symptoms before the age of 5 years. Parental consanguinity rate within the registered patients was 78% and a positive family history of PID was noticed in 50% of the patients. Genetic testing was performed in 69% of the patients with an overall diagnostic yield of 90%. Mutations were identified in 46 different genes and more than 90% of the reported genetic defects were transmitted by an autosomal recessive pattern. Intravenous immunoglobulins and stem cell transplantation were used in 58% and 25% of the patients, respectively. There were 81 deaths (26%) among the registered patients with a mean age of death of 25 months. 

Conclusions: PID is not infrequent in Kuwait and the reported prevalence is the highest in the literature with increased proportion of more severe forms. Collaborative efforts including introduction of newborn screening should be implemented to diagnose such cases earlier and improve the quality of life and prevent premature deaths.

Keywords: consanguinity; epidemiology; immunodeficiency; incidence; mortality; prevalence; registry.

Figures

Figure 1 The number (n = 314) and annual distribution of registered patients in KNPIDR between 2004 and 2018.

Figure 1 The number (n = 314) and annual distribution of registered patients in KNPIDR between 2004 and 2018.

Figure 2 The distribution of patients registered in KNPIDR according to PID categories.

Figure 2 The distribution of patients registered in KNPIDR according to PID categories.

Figure 3 Age distribution of patients registered in KNPIDR according to the onset and diagnosis age.

Figure 3 Age distribution of patients registered in KNPIDR according to the onset and diagnosis age.

Figure 4 The number (n = 62) and annual distribution of original research papers published in MEDLINE with patients' data gathered from KNPIDR between 2008 and 2018.

Figure 4 The number (n = 62) and annual distribution of original research papers published in MEDLINE with patients' data gathered from KNPIDR between 2008 and 2018.

Similar articles

Frequency and Manifestations of Autoimmunity Among Children Registered in the Kuwait National Primary Immunodeficiency Registry.

Massaad MJ, Zainal M, Al-Herz W.Front Immunol. 2020 Jun 2;11:1119. doi: 10.3389/fimmu.2020.01119. eCollection 2020.PMID: 32582199 Free PMC article.

Primary immunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry (2004--2006).

Al-Herz W.J Clin Immunol. 2008 Mar;28(2):186-93. doi: 10.1007/s10875-007-9144-5. Epub 2007 Nov 16.PMID: 18008151 Free PMC article.

Systematic Review of Primary Immunodeficiency Diseases in Malaysia: 1979-2020.

Abd Hamid IJ, Azman NA, Gennery AR, Mangantig E, Hashim IF, Zainudeen ZT.Front Immunol. 2020 Aug 26;11:1923. doi: 10.3389/fimmu.2020.01923. eCollection 2020.PMID: 32983118 Free PMC article.

Report of the Tunisian Registry of Primary Immunodeficiencies: 25-Years of Experience (1988-2012).

Mellouli F, Mustapha IB, Khaled MB, Besbes H, Ouederni M, Mekki N, Ali MB, Larguèche B, Hachicha M, Sfar T, Gueddiche N, Barsaoui S, Sammoud A, Boussetta K, Becher SB, Meherzi A, Guandoura N, Boughammoura L, Harbi A, Amri F, Bayoudh F, Jaballah NB, Tebib N, Bouaziz A, Mahfoudh A, Aloulou H, Mansour LB, Chabchoub I, Boussoffara R, Chemli J, Bouguila J, Hassayoun S, Hammami S, Habboul Z, Hamzaoui A, Ammar J, Barbouche MR, Bejaoui M.J Clin Immunol. 2015 Nov;35(8):745-53. doi: 10.1007/s10875-015-0206-9. Epub 2015 Oct 13.PMID: 26464197 Review.

Patterns of Primary Immunodeficiency Disorders Among a Highly Consanguineous Population: Cairo University Pediatric Hospital's 5-Year Experience.

Galal N, Meshaal S, Elhawary R, ElAziz DA, Alkady R, Lotfy S, Eldash A, Boutros J, Elmarsafy A.J Clin Immunol. 2016 Oct;36(7):649-55. doi: 10.1007/s10875-016-0314-1. Epub 2016 Aug 2.PMID: 27484503 Review.

Cited by

Primary immunodeficiencies in Bulgaria - achievements and challenges of the PID National Expert Center.

Naumova E, Lesichkova S, Milenova V, Yankova P, Murdjeva M, Mihailova S.Front Immunol. 2022 Sep 22;13:922752. doi: 10.3389/fimmu.2022.922752. eCollection 2022.PMID: 36211402 Free PMC article.

The yin and the yang of early classical pathway complement disorders.

Sullivan KE.Clin Exp Immunol. 2022 Aug 19;209(2):151-160. doi: 10.1093/cei/uxac056.PMID: 35648651 Free PMC article. Review.

Inborn Errors of Immunity in Algerian Children and Adults: A Single-Center Experience Over a Period of 13 Years (2008-2021).

Belaid B, Lamara Mahammed L, Drali O, Oussaid AM, Touri NS, Melzi S, Dehimi A, Berkani LM, Merah F, Larab Z, Allam I, Khemici O, Kirane SY, Boutaba M, Belbouab R, Bekkakcha H, Guedouar A, Chelali A, Baamara B, Noui D, Baaziz H, Rezak R, Azzouz SM, Aichaoui M, Moktefi A, Benhatchi RM, Oussalah M, Benaissa N, Laredj A, Bouchetara A, Adria A, Habireche B, Tounsi N, Dahmoun F, Touati R, Boucenna H, Bouferoua F, Sekfali L, Bouhafs N, Aboura R, Kherra S, Inouri Y, Dib S, Medouri N, Khelfaoui N, Redjedal A, Zelaci A, Yahiaoui S, Medjadj S, Touhami TK, Kadi A, Amireche F, Frada I, Houasnia S, Benarab K, Boubidi C, Ferhani Y, Benalioua H, Sokhal S, Benamar N, Aggoune S, Hadji K, Bellouti A, Rahmoune H, Boutrid N, Okka K, Ammour A, Saadoune H, Amroun M, Belhadj H, Ghanem A, Abbaz H, Boudrioua S, Zebiche B, Ayad A, Hamadache Z, Ouaras N, Achour N, Bouchair N, Boudiaf H, Bekkat-Berkani D, Maouche H, Bouzrar Z, Aissat L, Ibsaine O, Bioud B, Kedji L, Dahlouk D, Bensmina M, Radoui A, Bessahraoui M, Bensaadi N, Mekki A, Zeroual Z, Chan KW, Leung D, Tebaibia A, Ayoub S, Mekideche D, Gharnaout M, Casanova JL, Puel A, Lau YL, Cherif N, Ladj S, Smati L, Boukari R, Benhalla N, Djidjik R.Front Immunol. 2022 Apr 21;13:900091. doi: 10.3389/fimmu.2022.900091. eCollection 2022.PMID: 35529857 Free PMC article.

Immune Dysregulation in Monogenic Inborn Errors of Immunity in Oman: Over A Decade of Experience From a Single Tertiary Center.

Al Farsi T, Ahmed K, Alshekaili J, Al Kindi M, Cook M, Al-Hosni A, Ansari Z, Nasr I, Al Sukaiti N.Front Immunol. 2022 Apr 6;13:849694. doi: 10.3389/fimmu.2022.849694. eCollection 2022.PMID: 35464432 Free PMC article.

The Spectrum of Inborn Errors of Immunity in the United Arab Emirates: 5 Year Experience in a Tertiary Center.

Shendi HM, Al Kuwaiti AA, Al Dhaheri AD, Al-Hammadi S.Front Immunol. 2022 Jan 31;13:837243. doi: 10.3389/fimmu.2022.837243. eCollection 2022.PMID: 35173743 Free PMC article.

KMEL References

https://pubmed.ncbi.nlm.nih.gov/

References

  1.  
    1. Picard C, Bobby Gaspar H, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, et al. . International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol. (2018) 38:96–128. 10.1007/s10875-017-0464-9 - DOI - PMC - PubMed
  2.  
    1. Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, et al. . The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. (2019) 7:1763–70. 10.1016/j.jaip.2019.02.004 - DOI - PubMed
  3.  
    1. Al-Tamemi S, Naseem SU, Al-Siyabi N, El-Nour I, Al-Rawas A, Dennison D, et al. . Primary immunodeficiency diseases in oman: 10-year experience in a tertiary care hospital. J Clin Immunol. (2016) 36:785–92. 10.1007/s10875-016-0337-7 - DOI - PubMed
  4.  
    1. Errante PR, Franco JL, Espinosa-Rosales FJ, Sorensen R, Condino-Neto A. Advances in primary immunodeficiency diseases in Latin America: epidemiology, research, and perspectives. Ann N Y Acad Sci. (2012) 1250:62–72. 10.1111/j.1749-6632.2011.06289.x - DOI - PubMed
  5.  
    1. Gathmann B, Goldacker S, Klima M, Belohradsky BH, Notheis G, Ehl S, et al. . The German national registry for primary immunodeficiencies (PID). Clin Exp Immunol. (2013) 173:372–80. 10.1111/cei.12105 - DOI - PMC - PubMed
  6.  
    1. Mahlaoui N, Jais JP, Brosselin P, Mignot C, Beaurain B, Brito C, et al. Prevalence of primary immunodeficiencies in France is underestimated. J Allergy Clin Immunol. (2017) 40:1731–3. 10.1016/j.jaci.2017.06.020 - DOI - PubMed
  7.  
    1. Ishimura M, Takada H, Doi T, Imai K, Sasahara Y, Kanegane H, et al. . Nationwide survey of patients with primary immunodeficiency diseases in Japan. J Clin Immunol. (2011) 31:968–76. 10.1007/s10875-011-9594-7 - DOI - PubMed
  8.  
    1. Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol. (2007) 27:517–24. 10.1007/s10875-007-9105-z - DOI - PubMed
  9.  
    1. Stray-Pedersen A, Abrahamsen TG, Froland SS. Primary immunodeficiency diseases in Norway. J Clin Immunol. (2000) 20:477–85. 10.1023/A:1026416017763 - DOI - PubMed
  10.  
    1. Mellouli F, Mustapha IB, Khaled MB, Besbes H, Ouederni M, Mekki N, et al. . Report of the Tunisian Registry of Primary Immunodeficiencies: 25-Years of Experience (1988-2012). J Clin Immunol. (2015) 35:745–53. 10.1007/s10875-015-0206-9 - DOI - PubMed
  11.  
    1. Bousfiha AA, Jeddane L, El Hafidi N, Benajiba N, Rada N, El Bakkouri J, et al. . First report on the Moroccan registry of primary immunodeficiencies: 15 years of experience (1998-2012). J Clin Immunol. (2014) 34:459–68. 10.1007/s10875-014-0005-8 - DOI - PubMed
  12.  
    1. Shillitoe B, Bangs C, Guzman D, Gennery AR, Longhurst HJ, Slatter M, et al. . The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017. Clin Exp Immunol. (2018) 192:284–91. 10.1111/cei.13125 - DOI - PMC - PubMed
  13.  
    1. Ehlayel MS, Bener A, Laban MA. Primary immunodeficiency diseases in children: 15 year experience in a tertiary care medical center in Qatar. J Clin Immunol. (2013) 33:317–24. 10.1007/s10875-012-9812-y - DOI - PubMed
  14.  
    1. Abolhassani H, Kiaee F, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T, et al. . Fourth update on the iranian national registry of primary immunodeficiencies: Integration of molecular diagnosis. J Clin Immunol. (2018) 38:816–32. 10.1007/s10875-018-0556-1 - DOI - PubMed
  15.  
    1. Mayor PC, Eng KH, Singel KL, Abrams SI, Odunsi K, Moysich KB, et al. . Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry. J Allergy Clin Immunol. (2018) 141:1028–35. 10.1016/j.jaci.2017.05.024 - DOI - PMC - PubMed
  16.  
    1. Ruffner MA, USIDNET Body Weight Group. Sullivan KE. Complications associated with underweight primary immunodeficiency patients: prevalence and associations within the USIDNET registry. J Clin Immunol. (2018) 38:283–93. 10.1007/s10875-018-0492-0 - DOI - PMC - PubMed
  17.  
    1. Al-Herz W, Notarangelo LD, Sadek A, Buckley R. Combined immunodeficiency in the United States and Kuwait: Comparison of patients' characteristics and molecular diagnosis. Clin Immunol. (2015) 161:170–3. 10.1016/j.clim.2015.07.013 - DOI - PMC - PubMed
  18.  
    1. Al-Herz W, Moussa MA. Survival and predictors of death among primary immunodeficient patients: a registry-based study. J Clin Immunol. (2012) 32:467–73. 10.1007/s10875-011-9636-1 - DOI - PubMed
  19.  
    1. Al-Herz W, Chou J, Delmonte OM, Massaad MJ, Bainter W, Castagnoli R, et al. . Comprehensive genetic results for primary immunodeficiency disorders in a highly consanguineous population. Front Immunol. (2018) 9:3146. 10.3389/fimmu.2018.03146 - DOI - PMC - PubMed
  20.  
    1. Yazdani R, Abolhassani H, Kiaee F, Habibi S, Azizi G, Tavakol M, et al. . Comparison of common monogenic defects in a large predominantly antibody deficiency cohort. J Allergy Clin Immunol Pract. (2019) 7:864–78.e9. 10.1016/j.jaip.2018.09.004 - DOI - PubMed
  21.  
    1. Al-Herz W. Primary immunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry (2004–2006). J Clin Immunol. (2008) 28:186–93. 10.1007/s10875-007-9144-5 - DOI - PMC - PubMed
  22.  
    1. Al-Herz W, Ragupathy R, Massaad MJ, Al-Attiyah R, Nanda A, Engelhardt KR, et al. . Clinical, immunologic and genetic profiles of DOCK8-deficient patients in Kuwait. Clin Immunol. (2012) 143:266–72. 10.1016/j.clim.2012.03.002 - DOI - PMC - PubMed
  23.  
    1. Ludviksson BR, Sigurdardottir ST, Johannsson JH, Haraldsson A, Hardarson TO. Epidemiology of Primary Immunodeficiency in Iceland. J Clin Immunol. (2015) 35:75–9. 10.1007/s10875-014-0107-3 - DOI - PubMed

Page Navigation